Truist Financial Corp Bio N Tech Se Transaction History
Truist Financial Corp
- $62.7 Billion
- Q4 2024
A detailed history of Truist Financial Corp transactions in Bio N Tech Se stock. As of the latest transaction made, Truist Financial Corp holds 2,519 shares of BNTX stock, worth $296,259. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,519
Previous 3,409
26.11%
Holding current value
$296,259
Previous $404,000
28.96%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.22MShares$967 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$531 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$518 Million2.03% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$223 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$213 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...